Trials / Terminated
TerminatedNCT02281721
Surpass Flow Diverter for Intracranial Aneurysms: SURMOUNT Registry Data Collection
Prospective, Observational, Multi-Center, Single-Arm, Consecutive Enrollment, Post-Marketing, International Registry of the Surpass™ Flow Diverter in Intracranial Arteries
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (actual)
- Sponsor
- Stryker Neurovascular · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this observational post-marketing registry will be to collect and analyze safety, effectiveness, and quality of life outcomes, during and after treatment with the Surpass Flow Diverter. Health Economics assessments (cost data) will also be collected and analyzed.
Detailed description
This will be a prospective, observational, multi-center, single-arm, post-marketing, international registry with consecutive enrollment of a minimum of 150 patients treated with the Surpass Flow Diverter in accordance with the standard of care at up to 30 registry sites.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Surpass Flow Diverter(s) | Endovascular placement of a Surpass Flow Diverter(s) for the treatment of an intracranial aneurysm(s) |
Timeline
- Start date
- 2015-03-18
- Primary completion
- 2019-12-01
- Completion
- 2019-12-01
- First posted
- 2014-11-03
- Last updated
- 2021-07-14
Locations
19 sites across 9 countries: Belgium, Finland, France, Germany, Italy, Netherlands, Spain, Sweden, United Kingdom
Source: ClinicalTrials.gov record NCT02281721. Inclusion in this directory is not an endorsement.